Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is a rare subtype of non-Hodgkin lymphoma that frequently presents with multiorgan involvement. We report a diagnostically challenging ...

Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...

Mantle cell lymphoma is a cancer that often goes through phases of remission and relapse. During remission, doctors will continue to monitor a person for signs of relapse. They may also use certain ...

Diagnosing diffuse large B-cell lymphoma (DLBCL) often requires several lab tests and a physical evaluation. DLBCL is the most common subtype of non-Hodgkin’s lymphoma. It is an aggressive, ...

ALCL is a rare white blood cell cancer. Anyone can develop it, but people with breast implants may have a greater chance of developing a particular subtype. With treatment, the outlook is usually ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...

How Does Lunsumio Work for FL? Lunsumio is a special type of molecule that can attach to two different types of cells. This is called a bispecific antibody. It attaches to CD20 proteins on lymphoma ...

Stage 2 lymphoma is localized, affecting lymph nodes or a single extranodal site on one diaphragm side, with a favorable prognosis. Diagnosis involves biopsies, blood tests, and imaging to confirm ...

People with mantle cell lymphoma (MCL) often need to try different treatments to control their cancer. MCL can be hard to treat because it is aggressive and usually not curable. Jaypirca offers a new ...